LSTM Home > LSTM Research > LSTM Online Archive

Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis

Downloads

Downloads per month over past year

Tamarozzi, Francesca, Tendongfor, Nicholas, Enyong, Peter, Esum, Mathias, Faragher, Brian, Wanji, Samuel and Taylor, Mark (2012) 'Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis'. Parasites & Vectors, Vol 5, e53.

[img]
Preview
Text
Para_Vect_5_53.pdf - Published Version
Available under License Creative Commons Attribution.

Download (279kB) | Preview

Abstract

Background

Anti-Wolbachia treatment with doxycycline is effective in sterilising and killing adult Onchocerca volvulus nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of Loa loa co-endemicity. Nevertheless, the length of the required treatment poses potential logistical problems and risk of poor compliance, raising a barrier to the use of doxycycline in Mass Drug Administration (MDA) strategies. In 2007 and 2008 a feasibility trial of community-directed treatment with doxycycline was carried out in two health districts in Cameroon, co-endemic for O. volvulus and L. loa. With 17,519 eligible subjects, the therapeutic coverage was 73.8% with 97.5% compliance, encouraging the feasibility of using doxycycline community-directed delivery in restricted populations of this size. The current study evaluated the effectiveness of this community-directed delivery of doxycycline four years after delivery.

Findings

Infection with O. volvulus was evaluated by skin biopsy and nodule palpation. Of the 507 subjects recruited, 375 had completed the treatment with doxycycline followed by one or two rounds of annual ivermectin MDA and 132 received one or two rounds of annual ivermectin MDA alone. Statistically significant lower microfilarial prevalence (17.0% [doxycycline plus ivermectin group], 27.0% [ivermectin only group], p = 0.014) and load (p = 0.012) were found in people that had received doxycycline followed by ivermectin compared to those who received ivermectin only.

Conclusions

This study demonstrates the long-term effectiveness of doxycycline treatment delivered with a community-directed strategy even when evaluated four years after delivery in an area of ongoing transmission. This finding shows that a multi-week course of treatment is not a barrier to community-delivery of MDA in restricted populations of this size and supports its implementation to compliment existing control strategies for onchocerciasis, where needed.

Item Type: Article
Additional Information: The electronic version of this article is the complete one and can be found online at: http://www.parasitesandvectors.com/content/5/1/53
Subjects: QV Pharmacology > Anti-Bacterial Agents. Tissue Extracts > QV 360 Tetracyclines
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 885 Onchocerciasis
Faculty: Department: Groups (2002 - 2012) > Clinical Group
Groups (2002 - 2012) > Molecular & Biochemical Parasitology Group
Digital Object Identifer (DOI): https://doi.org/10.1186/1756-3305-5-53
Depositing User: Users 379 not found.
Date Deposited: 10 Sep 2012 09:53
Last Modified: 06 Feb 2018 13:05
URI: https://archive.lstmed.ac.uk/id/eprint/3012

Statistics

View details

Actions (login required)

Edit Item Edit Item